As of April 2024 InnovAge has a market cap of $0.54 Billion. This makes InnovAge the world's 5866th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.54 B | -33.33% |
2023 | $0.81 B | -16.24% |
2022 | $0.97 B | 43.66% |
2021 | $0.67 B |
On Apr 16th, 2024 the market cap of InnovAge was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Merck MRK | $317.56 B | 58,319.48% | ๐บ๐ธ USA |
Cocrystal Pharma
COCP | $14.54 M | -97.32% | ๐บ๐ธ USA |
AcelRx Pharmaceuticals
ACRX | $14.57 M | -97.32% | ๐บ๐ธ USA |
Horizon Therapeutics
HZNP | $26.63 B | 4,799.25% | ๐ฎ๐ช Ireland |